Blood product
Ended Purchase Order Awarded
- Contract number
- 75N91024P00152
- Awardee
-
Aldevron, L.l.c UEI GM49EPBCC4R7 Part of Danaher Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,210
Award facts
- Contract value 100% obligated
- $17,210.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Prairie Rose, ND 58104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,210 firm fixed price purchase order to Aldevron, L.L.C. for blood products. The place of performance will be in Prairie Rose, North Dakota and the contract is scheduled to be completed by March 5, 2024. Aldevron, L.L.C. is a subsidiary of Danaher Corporation. No set-aside designation was used for this contract award to support the National Cancer Institute's research efforts through the delivery of blood products.
Quick answers
Who was awarded contract 75N91024P00152?
75N91024P00152 was awarded to Aldevron, L.l.c by National Cancer Institute (National Institutes of Health) on January 5, 2024.
How much is contract 75N91024P00152 worth?
The government has obligated $17,210 on 75N91024P00152.
Was contract 75N91024P00152 competed?
The extent of competition for 75N91024P00152 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award